Incyclix.

Biotech Incyclix secured nearly $3 million in a $30 million round announced in 2022. The company's founders include PPD founder Fred Eshelman. It previously raised $12 million to develop a...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT